2985, cedar Brook drive

Decatur GA 30033

Global Neuroprotection Market 2020 and Forecast 2029

Global Neuroprotection Market 2020 and Forecast 2029

Published Date : 01-June-2020 | Pages : 200+ | Included Covid – 19 Impacted Analysis

Description

We, at CRR, have always studied the market in-depth and have been doing the pressure testing since our inception. Given the current pandemic situation, we all are of consensus that it is a constant now. Owing to which, the report addresses COVID-19 effects on this market too.

Key Companies :
Daiichi Sankyo Company
Eli Lilly and Company
Allergan
Dr. Reddy’s Laboratories
Teva Pharmaceutical
Novartis
AstraZeneca
Astrocyte Pharmaceuticals
F. Hoffmann-La Roche
Biogen

Market by Type :
Free Radical Trapping Agents (Antioxidants)
Glutamate Antagonists (Anti-Excitotoxic Agents)
Apoptosis Inhibitors
Anti-inflammatory Agents
Neurotrophic Factors (NTFs)
Metal Ion Chelators
Stimulants and Others

Market by Application :
Prevention
Treatment

By Region :
Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania
Europe : Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland
North America : United States, Canada, Mexico
Middle East & Africa : GCC, North Africa, South Africa
South America : Brazil, Argentina, Columbia, Chile, Peru

In this study, the years considered to estimate the market size of report are as follows:
History Year: 2013-2018
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2029
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Additional information

Select License

,

TOC

Chapter 1 Global Neuroprotection Market Overview
1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Neuroprotection Market
1.4 Restraints for Neuroprotection Market
1.5 Opportunities for Neuroprotection Market
1.6 Trends for Neuroprotection Market
1.7 COVID-19 Impact Assessment on Neuroprotection Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Neuroprotection Market Overview
2.1 Global Neuroprotection Market by Product Type
2.1.1 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Neuroprotection Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Neuroprotection Market by End User
2.2.1 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Neuroprotection Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Neuroprotection Market by Region
2.3.1 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Neuroprotection Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Neuroprotection Market Outlook (2013-2029)
2.4.1 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Neuroprotection Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Neuroprotection Market Y-o-Y Growth Rate by Region
2.8.2 Global Neuroprotection Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Neuroprotection Market Y-o-Y Growth Rate by End User
2.9 Global Neuroprotection Market Share Comparison (2013-2029)
2.9.1 Global Neuroprotection Market Share by Region
2.9.2 Global Neuroprotection Market Share by Product Type
2.9.3 Global Neuroprotection Market Share by End User

Chapter 3 North America Neuroprotection Market Overview
3.1 North America Neuroprotection Market by Product Type
3.1.1 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Neuroprotection Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Neuroprotection Market by End User
3.2.1 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Neuroprotection Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Neuroprotection Market by Region
3.3.1 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Neuroprotection Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Neuroprotection Market Outlook (2013-2029)
3.4.1 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Neuroprotection Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Neuroprotection Market Y-o-Y Growth Rate by Region
3.8.2 North America Neuroprotection Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Neuroprotection Market Y-o-Y Growth Rate by End User
3.9 North America Neuroprotection Market Share Comparison (2013-2029)
3.9.1 North America Neuroprotection Market Share by Region
3.9.2 North America Neuroprotection Market Share by Product Type
3.9.3 North America Neuroprotection Market Share by End User

Chapter 4 Europe Neuroprotection Market Overview
4.1 Europe Neuroprotection Market by Product Type
4.1.1 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Neuroprotection Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Neuroprotection Market by End User
4.2.1 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Neuroprotection Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Neuroprotection Market by Region
4.3.1 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Neuroprotection Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Neuroprotection Market Outlook (2013-2029)
4.4.1 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Neuroprotection Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Neuroprotection Market Y-o-Y Growth Rate by Region
4.8.2 Europe Neuroprotection Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Neuroprotection Market Y-o-Y Growth Rate by End User
4.9 Europe Neuroprotection Market Share Comparison (2013-2029)
4.9.1 Europe Neuroprotection Market Share by Region
4.9.2 Europe Neuroprotection Market Share by Product Type
4.9.3 Europe Neuroprotection Market Share by End User

Chapter 5 Asia Pacific Neuroprotection Market Overview
5.1 Asia Pacific Neuroprotection Market by Product Type
5.1.1 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Neuroprotection Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Neuroprotection Market by End User
5.2.1 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Neuroprotection Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Neuroprotection Market by Region
5.3.1 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Neuroprotection Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Neuroprotection Market Outlook (2013-2029)
5.4.1 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Neuroprotection Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Neuroprotection Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Neuroprotection Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Neuroprotection Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Neuroprotection Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Neuroprotection Market Share by Region
5.9.2 Asia Pacific Neuroprotection Market Share by Product Type
5.9.3 Asia Pacific Neuroprotection Market Share by End User

Chapter 6 South America Neuroprotection Market Overview
6.1 South America Neuroprotection Market by Product Type
6.1.1 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Neuroprotection Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Neuroprotection Market by End User
6.2.1 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Neuroprotection Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Neuroprotection Market by Region
6.3.1 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Neuroprotection Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Neuroprotection Market Outlook (2013-2029)
6.4.1 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Neuroprotection Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Neuroprotection Market Y-o-Y Growth Rate by Region
6.8.2 South America Neuroprotection Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Neuroprotection Market Y-o-Y Growth Rate by End User
6.9 South America Neuroprotection Market Share Comparison 2013-2029
6.9.1 South America Neuroprotection Market Share by Region
6.9.2 South America Neuroprotection Market Share by Product Type
6.9.3 South America Neuroprotection Market Share by End User

Chapter 7 MEA Neuroprotection Market Overview
7.1 MEA Neuroprotection Market by Product Type
7.1.1 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Neuroprotection Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Neuroprotection Market by End User
7.2.1 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Neuroprotection Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Neuroprotection Market by Region
7.3.1 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Neuroprotection Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Neuroprotection Market Outlook (2013-2029)
7.4.1 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Neuroprotection Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Neuroprotection Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Neuroprotection Market Y-o-Y Growth Rate by Region
7.8.2 MEA Neuroprotection Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Neuroprotection Market Y-o-Y Growth Rate by End User
7.9 MEA Neuroprotection Market Share Comparison (2013-2029)
7.9.1 MEA Neuroprotection Market Share by Region
7.9.2 MEA Neuroprotection Market Share by Product Type
7.9.3 MEA Neuroprotection Market Share by End User

Chapter 8 Global Neuroprotection Market Company Profiles
8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis…
Daiichi Sankyo Company
Eli Lilly and Company
Allergan
Dr. Reddy’s Laboratories
Teva Pharmaceutical
Novartis
AstraZeneca
Astrocyte Pharmaceuticals
F. Hoffmann-La Roche
Biogen

Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

$ 3900$ 7800

  • Corporate Price
  • Individual Price
Clear

For More Information

Email us at:

sales@credenceresearchreports.com

Call us at:

+1-925-478-7203